Notification [x]
My IM Status
Clinical Trials


Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine

Fallopian Tube Cancer Clinical Trials


A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Click on the closest state and city to find more detailed information on a research study in your area.

Alabama

Birmingham : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Mobile : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Alaska

Anchorage : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Arizona

Phoenix : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Tucson : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Gilbert : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Peoria : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Phoenix : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Phoenix : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Scottsdale :

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Tucson : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Tucson : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Tucson : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Tucson : University of Arizona Cancer Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

California

Los Angeles : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Los Angeles : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Stanford : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Burbank : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Corona : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Fullerton : Saint Jude Heritage Medical Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

La Jolla : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

La Jolla :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Long Beach : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Los Angeles : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Los Angeles :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Los Angeles : University of California Los Angeles

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Orange : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Oxnard : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Rancho Mirage : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Sacramento : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Sacramento : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Sacramento : UC Davis Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Diego : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

San Francisco :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

San Luis Obispo : Coastal Integrative Cancer Care

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Luis Obispo : Coastal Integrative Cancer Care

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Santa Maria : Central Coast Medical Oncology

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Santa Maria : Central Coast Medical Oncology

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Santa Monica : UCLA

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Stanford : Stanford University

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Colorado

Aurora : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Englewood : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Lakewood : Rocky Mountain Cancer Centers

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Lakewood : Rocky Mountain Cancer Centers

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Connecticut

Bridgeport : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Farmington : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Hartford : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

New Britain : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Stamford : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Florida

Sarasota : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Tampa : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Hollywood : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Miami : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Orlando : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Orlando : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Orlando : Florida Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sarasota : Sarah Cannon Research Institute

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sarasota : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

St. Petersburg : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Tampa : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Tampa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Georgia

Atlanta : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Savannah : Memorial University Medical Center

GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Savannah : Memorial University Medical Center

GOG 3001: A Phase III Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Augusta : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Gainesville : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Savannah : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Hawaii

Honolulu : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Illinois

Chicago : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Chicago : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Chicago : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Decatur : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Evanston : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Evanston :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Hinsdale : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Joliet : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Joliet :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Maywood : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Oak Lawn : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Park Ridge : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Urbana : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Indiana

Indianapolis : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Indianapolis : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Indianapolis : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Indianapolis : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Indianapolis : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Lafayette :

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Lafayette : Horizon BioAdvance

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Munster : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

South Bend : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Iowa

Ames : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Iowa City : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Iowa City :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Kansas

Kansas City : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Kentucky

Edgewood : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Lexington : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Louisiana

Covington : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Covington :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Lafayette : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Maine

Scarborough : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Maryland

Baltimore : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Baltimore : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Baltimore : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Baltimore :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Baltimore : Johns Hopkins Kimmel Cancer Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Massachusetts

Boston : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Boston : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Boston : Dana-Farber Cancer Institute

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston : Dana-Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Carcinoma

Boston : Massachusetts General Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Burlington : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Danvers : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Worcester : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Michigan

Detroit : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Detroit : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Detroit : Karmanos Cancer Institute

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Detroit :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Detroit : Karmanos Cancer Institute - Wayne State University

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Minnesota

Minneapolis : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Minneapolis : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Minneapolis :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Rochester : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study of Alvimopan and Placebo to evaluate Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Mississippi

Jackson : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Missouri

Kansas City : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

St. Louis : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

St. Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

St. Louis : Washington University School of Medicine

Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Peritoneal Cancer

Montana

Billings : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Nebraska

Lincoln : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Nevada

Henderson : Comprehensive Cancer Centers of Nevada

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Las Vegas : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Reno : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

New Hampshire

Lebanon : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

New Jersey

Morristown : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Hackensack : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Neptune : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

New Brunswick : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

New Mexico

Farmington : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Albuquerque : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Albuquerque : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

New York

Albany : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Bridgewater :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Brightwaters : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Buffalo : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Buffalo :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Jamaica : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Lake Success : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Mineola :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

New York : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

New York : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

New York : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study of Carboplatin, paclitaxel, and bevacizumab to evaluate Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

New York :

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Syracuse : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

North Carolina

Durham : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Winston-Salem : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Asheville : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Burlington : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Chapel Hill : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Charlotte : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Concord : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Durham : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Durham :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Durham : Duke Cancer Institute

Patients are needed to participate in a clinical research study evaluating BIBF 1120 for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Wilmington : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Winston-Salem : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Winston-Salem : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

North Dakota

Fargo : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Ohio

Toledo : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Akron : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Canton : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Cincinnati : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Cincinnati : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Cleveland : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Cleveland : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Cleveland : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Columbus : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Columbus : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Columbus : The Ohio State University Wexner Medical Center

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Columbus : The Ohio State University Wexner Medical Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Kettering : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Mayfield Heights : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Toledo : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Oklahoma

Oklahoma City : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Oklahoma City : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Oklahoma City :

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Oklahoma City : University of Oklahoma

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Oklahoma City : University of Oklahoma Health Sciences Center

Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Peritoneal Cancer

Tulsa : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Oregon

Bend : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Pennsylvania

Abington : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Abington : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Abington :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Bethlehem : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Philadelphia : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Philadelphia : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Philadelphia :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Philadelphia : Fox Chase Cancer Center

Patients are needed to participate in a clinical research study of Carboplatin, paclitaxel, and bevacizumab to evaluate Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

Philadelphia : Fox Chase Cancer Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Pittsburgh : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Pittsburgh : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Pittsburgh : Magee-Womens Hospital of UPMC

A clinical trial to evaluate treatments using intravenous docetaxel with intraperitoneal oxaliplatin and intravenous oxaliplatin with intraperitoneal docetaxel for patients with Ovarian Cancer, Peritoneal Cancer or Fallopian Tube Cancer

Pittsburgh : Magee-Womens Hospital of UPMC

A Phase 2 clinical study for patients with Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Radnor : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

West Reading : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Rhode Island

Providence : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Providence : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Providence : Women & Infants' Hospital

Patients are needed to participate in a clinical research study evaluating Panitumumab for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

South Carolina

Charleston : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Greenville : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Greenville :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

South Dakota

Sioux Falls : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Tennessee

Nashville : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Chattanooga : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Nashville : Sarah Cannon Research Institute

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Texas

Austin : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Dallas : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Fort Worth : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

San Antonio : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Woodlands : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Austin : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Austin : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Bedford : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Bedford : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Dallas : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Dallas : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Dallas : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Fort Worth : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Galveston : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Houston : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Houston : UTMD Anderson Cancer Clinical Lab

A Phase 1/Phase 2 clinical study for patients with Primary Peritoneal Carcinoma

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Houston : The University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Antonio : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

The Woodlands : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

The Woodlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Tyler : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Utah

Ogden : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Vermont

Burlington : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Virginia

Charlottesville : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Charlottesville : University of Virginia

A clinical research study of Gemcitabine and pazopanib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Charlottesville : University of Virginia

Patients are needed to participate in a clinical research study of Carboplatin, paclitaxel, and bevacizumab to evaluate Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

Norfolk : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Roanoke : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Winchester : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Woodbridge : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Washington

Vancouver : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Seattle : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Tacoma : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Wenatchee : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Wisconsin

Green Bay : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Green Bay : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Marshfield : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Milwaukee : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Milwaukee : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Milwaukee : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Oshkosh : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Sheboygan : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Waukesha : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Wausau : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

West Allis : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Australia

Adelaide : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Bedfork Park : Flinders Cancer Clinic - Flinders Medical Centre (FMC)

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Bendigo :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Greenslopes : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Heidelberg :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Herston :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Herston : Royal Brisbane & Women's Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Milton :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Nedlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Parkville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Parkville : Royal Melbourne Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Parkville : Royal Melbourne Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Randwick :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Subiaco : St John of God Hospital Subiaco

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sydney : Prince of Wales Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sydney : Prince of Wales Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Westmead : Westmead Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Westmead : Crown Princess Mary Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Austria

Graz : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Innsbruck : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Graz : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Graz : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Innsbruck : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Linz : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Salzburg : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Wien : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Belgium

Leuven : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Bonheiden : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Brasschaat : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Bruxelles : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Charleroi : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Edegem : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Gent : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Hasselt : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Leuven : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Leuven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Libramont : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Liège : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Liège : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Namur : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Sint-Niklaas : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Turnhout : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Wilrijk : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Yvoir : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Canada

Calgary : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Calgary :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Edmonton : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Halifax : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

London : London Regional Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Montreal : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Montreal :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Ottawa : Ottawa Hospital Cancer Centre

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Ottawa : Ottawa Hospital Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sault Ste. Marie : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Toronto : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Toronto : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Toronto :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Toronto : Princess Margaret Cancer Centre

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Toronto : Princess Margaret Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Denmark

Aalborg : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Copenhagen : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Herlev : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Odense : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Herlev : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

København Ø : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

France

Lille : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Montpellier : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Nice : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

St. Herblain Cedex : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Bordeaux : Institut Bergonie

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Germany

Aalen : Ostalbklinikum

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Berlin : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Berlin : Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik für Frauenheilkunde

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Dresden : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Düsseldorf : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Düsseldorf : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Erlangen : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Erlangen : Univerisity Hospital; Dept. of Gynecology & Obstetrics

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Essen : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Essen : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Essen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Essen : University hospital, Dept. of gynecology & obstetrics

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Esslingen : Klinikum Esslingen

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Frankfurt am Main : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Frankfurt am Main : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Frankfurt am Main : Klinikum der JWG Universität Frankfurt

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Freiburg : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Freiburg : Universitätsklinikum Freiburg, Frauenklinik

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Greifswald : Gynecologic Clinic of the Ernst-Moritz-Arndt-University

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Hamburg : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Hannover : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Hannover : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Hannover : Medizinische Hochschule

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Kiel : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Kiel : Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik f. Gynäkologie u. Geburtshilfe

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Konstanz : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Leipzig : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Ludwigsburg : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Mainz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Marburg : Klinikum der Philipps-Universität Marburg, Klinik für Gynäkologie, Gynäkologische Endokrinologie

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

München : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

München : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

München : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Munich : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Offenburg : St. Josefsklinik

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Oldenburg : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Paderborn : St. Vincenz-Krankenhaus

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Ravensburg : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Rostock : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Rostock : Klinikum Südstadt

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Stuttgart : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Tübingen : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Ulm : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Ulm : Universitätsklinikum, Universitätsfrauenklinik

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Wiesbaden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Wiesbaden : HSK, Dr. Horst Schmidt Klinik GmbH

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Wolfsburg : Klinikum der Stadt Wolfsburg

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Greece

Athens : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Athens : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Athens : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Athens : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Larissa : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Patra : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Thessaloniki : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Hong Kong

Hong Kong : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Kowloon : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

New Territories : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

India

Bangalore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Cuttack : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Hyderabaad : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

New Delhi : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Pune : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Italy

Avellino : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Aviano PN : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Bari : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Bologna : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Brescia : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Genova : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Milano : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Milano : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Napoli : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Novara : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Palermo : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Pisa : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Roma : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Roma : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Torino : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Japan

Fukuoka-shi : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Kashiwa : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Kitaadachi-gun : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Kure-city : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Kurume-city : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Morioka-city : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Nagoya-city : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Sapporo-city : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Suntou-gun : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Tokyo : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Tokyo : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Yonago-city : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Korea, Republic of

Goyang-si, Gyeonggi-do : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Seoul : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Seoul : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Seoul : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Netherlands

Leiden : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Nijmegen : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Rotterdam : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Norway

Bergen : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Oslo : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Poland

Bialystok : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Gdansk : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Russian Federation

Chelyabinsk : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Ekaterinburg :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Ivanovo : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Izhevsk :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Krasnodar : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Krasnodar :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Kursk :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Moscow : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Moscow :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Obninsk : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Orenburg :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Pyatigorsk : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Saint Petersburg : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

St. Petersburg :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Ufa : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Ufa :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Voronezh : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Spain

Barcelona : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Madrid : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Palma de Mallorca : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Badalona : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Barcelona : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Barcelona : Hospital Vall D'Hebron

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Barcelona : Hospital Vall d'Hebron

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

El Palmar : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Girona : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Lleida : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Madrid : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Madrid : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Madrid : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Madrid : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Madrid : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Madrid : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Madrid : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Madrid : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Oviedo : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Palma de Mallorca : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Valencia : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Valencia : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Zaragoza : Research Site

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Sweden

Lund : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Stockholm : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Ukraine

Chernivtsi :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Dnepropetrovsk :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Kharkiv :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Lutsk :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

United Kingdom

Kent : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

London : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

London : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Nottingham : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Somerset : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Wirral : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Bebington : The Clatterbridge Cancer Centre NHS Foundation Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Bebington :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Cardiff :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Edinburgh :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Glasgow :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Guildford : Royal Surrey County Hospital NHS Foundation Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Keighley :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Leeds : Leeds Teaching Hospitals NHS Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Leeds :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Liverpool :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

London : University College London Cancer Institute

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Manchester : The Christie NHS Foundation Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Manchester :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Nottingham :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Oxford : Oxford University Hospitals NHS Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Oxford :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Plymouth : Plymouth Hospitals NHS Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

West Midlands :

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Quick Search
Powered by DZOIC Handshakes Professional